Back to Search
Start Over
Click Therapeutics Receives FDA Breakthrough Device Designation for Prescription Digital Therapeutic to Treat Episodic Migraine
- Source :
- Business Wire. December 16, 2022
- Publication Year :
- 2022
-
Abstract
- NEW YORK -- Click Therapeutics, Inc. ('Click'), a leader in Digital Therapeutics[TM] as prescription medical treatments, today announced that it has received Breakthrough Device Designation from the U.S. Food and [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- Business Wire
- Publication Type :
- News
- Accession number :
- edsgcl.730242360